A meta-analysis of topical prostaglandin analogues intra-ocular pressure lowering in glaucoma therapy

Authors: Denis, P.h.1; Lafuma, A.2; Khoshnood, B.3; Mimaud, V.2; Berdeaux, G.4

Source: Current Medical Research and Opinion, Volume 23, Number 3, March 2007 , pp. 601-608(8)

Publisher: Informa Healthcare

Key:
Free Content - Free Content
New Content - New Content
Subscribed Content - Subscribed Content
Free Trial Content - Free Trial Content

Abstract:

Objective: To compare the efficacy of latanoprost, bimatoprost and travoprost for lowering IOP in patients with glaucoma.

Research design and methods: In order to carry out this meta-analysis, randomized trials (2001-2004) were identified on Medline and EMBASE using the following key words: glaucoma, ocular hypertension (OHT), randomization, trial, latanoprost, bimatoprost and travoprost. The studies had to compare at least two prostaglandin analogues as mono-therapy. Cross-over experimental designs were excluded. The main outcome measure was IOP at final visit. Statistical analyses included random effects, pooled estimates of treatment effects, tests for publication bias, and random-effects models to obtain adjusted treatment effects on final IOP after lowering for baseline IOP, and duration of follow-up. Random effects Poisson regression models were used to estimate the adjusted effects of treatments on response rates (IOP < 18 mmHg).

Results: Nine studies were used in the analysis. Patient mean age varied from 56.7 to 68.8 years and baseline IOP ranged from 22.3 to 26.5 mmHg. Three hundred and seventy-eight patients were treated with bimatoprost, 385 with travoprost and 555 with latanoprost. Patients treated with travoprost and bimatoprost had lower IOP levels at the end of follow-up (−0.98 mmHg [95% CI: −2.08; 0.13; p = 0.08] and −1.04 mmHg [95% CI: −2.11;0.04; p = 0.06], respectively) than those treated with latanoprost. The combined effect of newer prostaglandin analogues (bimatoprost/travoprost) was an adjusted decrease of 1.00 mmHg [95% CI: −1.91;−0.10], p = 0.03], or a 17% higher adjusted response rate (Incidence Rate Ratio 1.17, 95% CI, 1.00-1.35, p = 0.04), compared to latanoprost.

Conclusion: Travoprost and bimatoprost may have greater efficacy in lowering IOP for patients with OHT or glaucoma.

Keywords: EFFICACY; GLAUCOMA; INTRA-OCULAR PRESSURE; META ANALYSIS; PROSTAGLANDIN ANALOGUES

Document Type: Research article

DOI: 10.1185/030079907X178720

Affiliations: 1: Hôpital Edouard Herriot, Service d'ophtalmologie, 5, Place Arsonval, F-69003 Lyon, France 2: Cemka Eval, 43 boulevard du Maréchal Joffre, F-92340 Bourg la Reine, France 3: AlconFrance, 4 rue Henri Sainte-Claire Deville, F-92653 Rueil Malmaison, France 4: AlconFrance, 4 rue Henri Sainte-Claire Deville, F-92653 Rueil Malmaison, France; Conservatoire National des Arts et Métiers, 292, rue Saint-Martin, 75003 Paris, France

The full text electronic article is available for purchase. You will be able to download the full text electronic article after payment.

$51.50 plus tax      Refund Policy

 

OR

Back to top

Key:
Free Content - Free Content
New Content - New Content
Subscribed Content - Subscribed Content
Free Trial Content - Free Trial Content
Share this item with others: These icons link to social bookmarking sites where readers can share and discover new web pages.
Page Help Click here for Page Help
Shopping cart
Tools
Sign in






Need to register?
Sign up here
Text size: A | A | A | A